Milestone Scientific Inc. (MLSS) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
MLSS Revenue Growth
Revenue Breakdown (FY 2015)
MLSS's revenue distribution by segment and geography for fiscal year 2015
By Product/Segment
By Geography
MLSS Revenue Analysis (2013–2024)
As of May 8, 2026, Milestone Scientific Inc. (MLSS) generated trailing twelve-month (TTM) revenue of $9.1 million, reflecting exceptional growth of +25.3% year-over-year. The most recent quarter (Q2 2025) recorded $2.3 million in revenue, up 4.1% sequentially.
Looking at the longer-term picture, MLSS's 5-year compound annual growth rate (CAGR) stands at +0.6%, indicating moderate growth over time. The company achieved its highest annual revenue of $11.3 million in 2017.
Revenue diversification analysis shows MLSS's business is primarily driven by Handpieces (100%). With over half of revenue concentrated in Handpieces, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including XRAY (-1.0% YoY), HSIC (+4.0% YoY), and NVST (+12.1% YoY), MLSS has outperformed the peer group in terms of revenue growth. Compare MLSS vs XRAY →
MLSS Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| MLSSCurrent | $9M | +25.3% | +0.6% | -78.3% | |
 XRAY | $3.7B | -1.0% | +2.0% | 6.8% | |
 HSIC | $13.2B | +4.0% | +5.4% | 5.7% | |
 NVST | $2.7B | +12.1% | +7.1% | 8.3% | |
 ALGN | $4.0B | +2.9% | +10.3% | 15.3% | |
 SRDX | $126M | -0.0% | +4.7% | -4.5% |
MLSS Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $8.6M | -12.2% | $6.4M | 74.6% | $-6,756,957 | -78.3% |
| 2023 | $9.8M | +11.6% | $6.8M | 69.1% | $-7,106,474 | -72.3% |
| 2022 | $8.8M | -14.5% | $4.9M | 55.7% | $-8,827,473 | -100.2% |
| 2021 | $10.3M | +89.5% | $6.3M | 61.3% | $-7,378,508 | -71.6% |
| 2020 | $5.4M | -35.1% | $3.6M | 66.6% | $-7,453,118 | -137.1% |
| 2019 | $8.4M | -13.0% | $5.7M | 68.3% | $-3,998,993 | -47.8% |
| 2018 | $9.6M | -14.7% | $4.4M | 46.1% | $-7,999,335 | -83.1% |
| 2017 | $11.3M | +7.6% | $7.0M | 61.8% | $-5,234,318 | -46.4% |
| 2016 | $10.5M | +10.4% | $6.3M | 60.2% | $-6,513,960 | -62.1% |
| 2015 | $9.5M | -8.1% | $6.4M | 67.9% | $-3,056,748 | -32.2% |
See MLSS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MLSS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MLSS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMLSS — Frequently Asked Questions
Quick answers to the most common questions about buying MLSS stock.
Is MLSS's revenue growth accelerating or slowing?
MLSS revenue is accelerating at +25.3% year-over-year, exceeding the 5-year CAGR of +0.6%. TTM revenue reached $9M. Growth momentum has increased versus prior periods.
What is MLSS's long-term revenue growth rate?
Milestone Scientific Inc.'s 5-year revenue CAGR of +0.6% reflects the sustained expansion pattern. Current YoY growth of +25.3% is above this long-term average.
How is MLSS's revenue distributed by segment?
MLSS reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.